Maso Capital Partners LTD Takeda Pharmaceutical CO LTD Transaction History

Maso Capital Partners LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $1.53 Million - $1.82 Million	-91,367 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $1.3 Million - $1.6 Million	-84,432 Reduced 48.03%	91,367 $1.66 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $700,535 - $786,156	-40,967 Reduced 18.9%	175,799 $3.14 Million
Q1 2020 May 11, 2020	BUY	$13.02 - $20.31 $457,535 - $713,713	35,141 Added 19.35%	216,766 $3.29 Million
Q4 2019 Feb 12, 2020	BUY	$16.88 - $20.83 $909,055 - $1.12 Million	53,854 Added 42.15%	181,625 $3.58 Million
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $26,527 - $32,784	-1,600 Reduced 1.24%	127,771 $2.26 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $2.16 Million - $2.78 Million	129,371 New	129,371 $2.64 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Maso Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Maso Capital Partners LTD with notifications on news.